Developing a Copper(II) Isopropyl 2-Pyridyl Ketone Thiosemicarbazone Compound Based on the IB Subdomain of Human Serum Albumin-Indomethacin Complex: Inhibiting Tumor Growth by Remodeling the Tumor Microenvironment

Xueyu Man,Shanhe Li,Gang Xu,Wenjuan Li,Minghui Zhu,Zhenlei Zhang,Hong Liang,Feng Yang

DOI: https://doi.org/10.1021/acs.jmedchem.3c02378

IF: 8.039

2024-03-31

Journal of Medicinal Chemistry

Abstract:To develop a next-generation metal agent and dual-agent multitargeted combination therapy, we developed a copper (Cu) compound based on the properties of the human serum albumin (HSA)-indomethacin (IND) complex to remodel the tumor microenvironment (TME). We optimized a series of Cu(II) isopropyl 2-pyridyl ketone thiosemicarbazone compounds to obtain a Cu(II) compound (C4) with significant cytotoxicity and then constructed an HSA-IND-C4 complex (HSA-IND-C4) delivery system. IND and C4 bind to...

chemistry, medicinal